With metronomic chemotherapy, patients receive low-dose chemotherapy over a regular and long period.
Metronomic chemotherapy is not only directed against the tumor, but also its surroundings. For example, it inhibits tumor vessels by inhibiting growth factors that are directly responsible for the production of new cancer vessels.
Amazingly, metronomic chemotherapy also works by activating our immune system. Specific immune cells, the so-called regulatory T cells, suppress the immune system, and go hand in hand with tumor growth. Metronomic chemotherapy inhibits these immune cells and thus removes the suppression of the immune system.
Metronomic chemotherapy also has direct effects on cancer cells. Studies show that it can inhibit cancer cell growth and improve treatment outcomes.
According to studies, metronomic chemotherapy can be used in the treatment of the following types of cancer: Breast cancer, lung cancer, prostate cancer, brain tumor, colon cancer, multiple myeloma, lymphoma, and liver cancer.
Metronomic chemotherapy has proven its effectiveness in numerous studies. I’ve been using it for many years. It can also be used if classic chemotherapy has not been successful before or if the patient has already been weakened by previous treatments.